Kenneth Peters, MD
Urology · Royal Oak, MINPI 1417948944
Payments from drug & device makers
Across 210 payments — averaging $2810.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$121K
- Coloplast$119K
- Urovant Sciences Inc$117K
- Inspire Medical Systems, Inc.$96K
- Ironwood Pharmaceuticals, Inc$85K
- Medtronic$23K
- plus $29K from 26 others
Across 2 payments — averaging $3961.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $121,431 |
| Coloplast | 31 | $118,716 |
| Urovant Sciences Inc | 28 | $117,351 |
| Inspire Medical Systems, Inc. | 7 | $95,658 |
| Ironwood Pharmaceuticals, Inc | 22 | $84,622 |
| Medtronic(2 entities) | 31 | $23,011 |
| Axonics, Inc. | 10 | $14,166 |
| Cook Research Incorporated | 10 | $9,261 |
| Boston Scientific | 4 | $1,569 |
| Purdue Pharma L.p. | 1 | $1,230 |
| Janssen Research & Development, LLC | 1 | $833 |
| Minze Health, Inc | 1 | $825 |
| Stimwave Technologies Incorporated | 2 | $436 |
| Astellas Pharma US Inc | 11 | $336 |
| AbbVie(2 entities) | 13 | $216 |
| C. R. Bard, Inc. & Subsidiaries | 8 | $125 |
| Laborie Medical Technologies Corp. | 1 | $82 |
| Contura, Inc. | 1 | $77 |
| Olympus America Inc. | 1 | $51 |
| Rochester Medical Corporation | 2 | $44 |
| Curonix LLC | 1 | $27 |
| Johnson & Johnson | 2 | $27 |
| Merck | 1 | $23 |
| 180 Medical, Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Clarus Therapeutics Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Sagent Pharmaceuticals | 1 | $13 |
| Tolmar Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$590,266 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Royal Oak
- Adam GadzinskiRoyal Oak$727K
- Richard BennettRoyal Oak$368K
- Jason GilleranRoyal Oak$28K
- Sugandh ShettyRoyal Oak$20K
- Jason HafronWest Bloomfield$9.9M
- Ashok ReddySterling Heights$4.9M
- Kenneth KernenTroy$3.4M
- James PeabodyDetroit$2.1M
- William RobertsAnn Arbor$973K
- William JohnstonLivonia$675K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.